Pharmaceutical Companies Update
Updates on drug companies, from the latest company formations and mutually beneficial mergers to the acquisitions by the pharmaceutical industry's giants.
- July 2009 Updates
Almac Discovery is an independent member of the Almac Group which develops novel anticancer therapies.
Aragon Pharmaceuticals is developing novel small molecule therapies for the treatment of hormone-resistant cancers.
Archivel Farma, spun out from Archivel Technologies in 2005, is developing novel therapeutics for the treatment and prevention of tuberculosis and other diseases.
Artificial Cell Technologies is an early-stage biotechnology company concerned with the development of novel vaccines for the treatment of infectious diseases.
more - June 2009 Updates
Anergis is using its Contiguous Overlapping Peptides platform to develop immunotherapies for the treatment of allergies.
Applied Protein Sciences is a biotech company focused on the treatment and prevention of chemotherapy-induced mucositis.
Autoimmune Technologies is developing antiviral peptides based on technology licensed from Tulane University School of Medicine.
Biomed Research & Technologies is developing a therapy for atopic dermatitis.
more - May 2009 Updates
ACT Biotech was spun off from Bayer Healthcare to develop and commercialise targeted oral anticancers.
Adaptimmune is a biotech outfit focusing on the development of T-cell therapies for cancer and infectious disease.
Alnara Pharmaceuticals is developing protein therapeutics for the treatment of metabolic disease.
Binex is a S Korean biotech company.
more - April 2009 Updates
Alios is developing novel antivirals based on three platform technologies.
American Oriental Bioengineering is developing traditional Chinese medicines for pharmaceutical use.
Calixa Therapeutics is focused on developing, acquiring and commercialising hospital-based anti-infectives.
CDG Therapeutics is developing proprietary bacteria-derived peptides as cytotoxic agents for the treatment of cancer.
more - March 2009 Updates
Chaksu Research is developing treatments for degenerative ocular disease.
Garnet BioTherapeutics is a biotech outfit, developing their lead GBT-009 for various indications.
Genyous Biomed is focused on developing anticancers.
Omnitura Therapeutics is developing anticancers.
more - February 2009 Updates
AcelRx is a pharmaceutical company developing treatments for intermittent and acute pain conditions.
Anaphore is a biotechnology company, focused on developing Atrimers, drug candidates from fully-human serum protein, for use in treating immune-mediated diseases and cancer.
Angion Biomedica develops molecular drug candidates that target reparative and regenerative processes for therapeutic benefit, focusing primarily on diseases related to tissue and organ injury as well as on fibrosis.
more - January 2009 Updates
Avineuro is a pharmaceutical company discovering and developing novel small molecules for unmet medical needs in neurology and psychiatry.
BioCis is a drug development company focused on investigation of treatments for inflammation, allergy and cancer.
Capricor is a biotechnology company focused on the development of stem cell therapies for the treatment of heart disease.
Chaperone Technologies is a biotechnology company developing a new class of anti-microbials.
more - December 2008 Updates
Andromeda Biotech, a wholly-owned subsidiary of Clal Biotechnology Industries, is developing treatments for autoimmune diabetes.
Archer Pharmaceuticals focuses on targeted drug discovery for Alzheimer's disease.
China-based Botanic Century is engaged in the development of plant-based on traditional Chinese medicine for the treatment of a variety of diseases.
Calabar AB is a privately-owned company that aims to develop xerostomia therapeutics.
more - November 2008 Updates
4-antibody is a biotechnology company developing fully-human antibodies, for the treatment of autoimmune and inflammatory diseases as well as cancer.
Adeona Pharmaceuticals develops autoimmune therapeutics.
China-based Botanic Century is engaged in the development of plant-based on traditional Chinese medicine for the treatment of a variety of diseases.
Esperance Pharmaceuticals is a biopharmaceutical company developing selective and targeted anticancer drugs.
more - October 2008 Updates
Andromeda Biotech, a wholly-owned subsidiary of Clal Biotechnology Industries, is developing treatments for autoimmune diabetes.
Archer Pharmaceuticals focuses on targeted drug discovery for Alzheimer's disease.
Arisyn is a privately-held biotech company developing novel inhibitors of infectious diseases and cancer.
Atani is developing and commercializing novel anticancers in Japan.
more - September 2008 Updates
Alte Biosciences is a virtual pharmaceutical company developing drugs for debilitating chronic diseases.
Apoptos is developing small-molecule anticancer drugs that activate apoptosis.
BexCore is a biopharmaceutical company that develops novel drug candidates and delivery systems.
BiolActis is a Canadian biotech company engaged in the development and commercialization of drugs for the treatment of metabolic diseases and obesity-related conditions.
more - August 2008 Updates
Abeome is a biotech outfit investigating high-affinity monoclonal antibodies.
Adienne is an integrated biopharmaceutical company dedicated to the treatment of rare and severe diseases.
Altair Therapeutics was formed to develop Isis Pharmaceuticals' antisense drugs for respiratory disease.
Amplimmune is developing immune-based biologics to treat patients in the areas of cancer, autoimmunity, transplantation and infectious diseases.
more - July 2008 Updates
Alopexx is developing novel products for the treatment and prevention of MRSA and other serious infections.
AMRI is a global company that provides scientific services, products and technologies.
Armgo Pharma is developing small-molecule therapeutics, known as 'rycals', which target the ryanodine receptor/calcium release channel for the treatment of cardiac, muscular and neurological disorders.
more - June 2008 Updates
Activus Pharma combines organic chemistry, biological redox measurement and nano-particulation technology for creating new therapies for the control of diseases.
Altheus Therapeutics is identifies and implements pharmaceutical strategies for the treatment of inflammatory bowel disease.
ApopLogic Pharmaceuticals is a biotechnology company focused on the development of compounds for the treatment of cancer.
more - June 2008 Updates
Activus Pharma combines organic chemistry, biological redox measurement and nano-particulation technology for creating new therapies for the control of diseases.
Altheus Therapeutics is identifies and implements pharmaceutical strategies for the treatment of inflammatory bowel disease.
ApopLogic Pharmaceuticals is a biotechnology company focused on the development of compounds for the treatment of cancer.
more - May 2008 Updates
Akebia is a spin-off company from Proctor & Gamble focused on the development of treatments for ischaemia and improvement of vascular disease.
Alfama is a pharmaceutical company dedicated to the development of small-molecule drugs to combat inflammation-related diseases.
Alize Pharma is a group of privately-held biopharmaceuticals specializing in the development of therapeutics for metabolic diseases and cancer.
more - April 2008 Updates
Arno Therapeutics is developing innovative anticancers.
Airmid is a virtual pharmaceutical company focused on the development and commercialization of treatments for autoimmune disorders, concerned with the Kv1.3 potassium channel.
AKL International develops drugs derived from botanical sources.
more - March 2008 Updates
Advanced Cancer Therapeutics is a pharmaceutical company focused on the discovery and early development of cancer therapeutics.
Privately-owned Alphamed Pharmaceuticals is engaged in the development of prescription and over-the-counter products for human and animal use.
more - February 2008 Updates
Beijing Mefuvir Medicinal Technology conducts the pharmaceutical business of its Chinese parent company Wuhun Humanwell Hi-tech Industry.
Biovascular is a biotechnology company developing drugs and devices for the control of intimal hyperplasia.
more - January 2008 Updates
Anza Therapeutics is a company formed around the spin-off of Cerus' immunotherapy assets, which include Listeria and KBMA platform technologies.
Derma Sciences is a fully-integrated manufacturer, marketer and supplier of a complete line of products for wound and skin care.
more - December 2007 Updates
Clarus Therapeutics is dedicated to the development and commercialization of androgen-based therapeutics.
Inspiration Therapeutics is engaged in the development of innovative blood recombinant blood coagulation factor products to fundamentally change the treatment of hemophilia.
more - November 2007 Updates
Aquinox Pharmaceuticals is interested in the development and commercialisation of novel and targeted small molecules for the treatment of cancer and inflammatory disease.
AlloCure is focused on the development of stem cell therapies for the treatment of various indications.
more - October 2007 Updates
Bio-Ker is developing biosimilars, recombinant proteins, controlled-delivery systems and therapeutic plasmid DNA vaccines.
CG Therapeutics is a biotechnology company developing cancer therapeutics focused on inhibiting hCG
more - September 2007 Updates
Norwegian company, Bio-Medisinsk Innovasjon develops drugs based on compounds that interfere with serotonin.
DiaMedica is developing treatments for all stages of Type II diabetes, by repostioning existing drugs and developing NCEs.
more - August 2007 Updates
AB Science is a French company developing an anticancer drug.
Akela Pharma focuses on the development of inhalation treatments for pain and CNS disorders.
Privately-owned Alacrity Biosciences is focused on the development of treatments for ocular surface diseases, retinal diseases and glaucoma.
more - July 2007 Updates
Advancis Pharmaceuticals has changed its name to MiddleBrook Pharmaceuticals.
Alteon has acquired Israeli Company HaptoGuard.
Amgen has acquired Iilypsa, a private company developing non-absorbed drugs for renal disorders.
more - June 2007 Updates
Coronado Biosciences is engaged in developing novel and proprietary cancer therapeutics.
Pfizer has acquired privately-owned biopharmaceutical company BioRexis.
more - May 2007 Updates
Autoimmune focussed company, The Immune Response Corporation has changed its name to Orchestra Therapeutics.
Metabolic Research develops non-synthetic compounds for the treatment of arthritis, heart disease, metabolic and inflammatory diseases and cancer.
more - April 2007 Updates
Biogen Idec has acquired the biopharmaceutical company Syntonix, which remains as a wholly-owned subsidiary.
Biopharmaceutical company Endotis Pharma operates in the field of therapeutic glyomics and is investigating the use of oligosaccharide-based drugs in the fields of oncology and thrombosis.
more - March 2007 Updates
US giant Eli Lilly has acquired ICOS, which will remain a wholly-owned subsidiary.
OBEcure is an Israeli drug discovery company, focused on the development of antiobesity therapies.
more - February 2007 Updates
Merck KGaA has taken over Serono, which will become a subsidiary under the name Merck Serono
CoDa Therapeutics is developing novel wound healing products based on gap junction modulation.
more - January 2007 Updates
Crucell has acquired Stockholm-based SBL Vaccin AB
BioProgress is using its proprietary polymer technology to develop and enhance its own pharmaceutical products and those of its partners.
more - December 2006 Updates
Amgen latest acquisition is Avidia
Amorcyte is a therapeutics company pursuing cellbased therapies for cardiovascular diseases.
more - October 2006 Updates
Athenagen and Zapaq have merged to form a neurology-focused company, Athenagen
Axordia is a UK-based human embryonic stem cell company.
more
